Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.28 | 9e-18 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.28 | 2e-16 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.25 | 1e-14 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.26 | 3e-14 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.26 | 3e-14 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.24 | 4e-14 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.26 | 8e-14 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.25 | 5e-13 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.24 | 2e-12 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.24 | 7e-12 |